会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明申请
    • USES, METHODS, KITS, COMPOSITIONS AND ANTIBODIES FOR IDENTIFYING HEMATOPOIETIC CELL SUBTYPES
    • 用于鉴别造血细胞亚型的用途,方法,试剂盒,组合物和抗体
    • WO2018073267A1
    • 2018-04-26
    • PCT/EP2017/076517
    • 2017-10-17
    • OSPEDALE SAN RAFFAELE S.R.L.FONDAZIONE TELETHON
    • BASSO-RICCI, LucaBIASCO, LucaAIUTI, Alessandro
    • G01N15/14G01N33/50G01N33/532G01N33/533
    • G01N15/1459G01N33/5094G01N33/582G01N2015/1006G01N2015/1402
    • Use of (i) an anti-CD3 antibody, (ii) an anti-CD56 antibody, (iii) an anti-CD14 antibody, (iv) an anti-CD38 antibody, (v) an anti-CD45 antibody, (vi) an anti-CD90 antibody, (vii) an anti- CD135 antibody, (viii) an anti-CD10 antibody, (ix) an anti-CD11c antibody, (x) an anti-CD19 antibody, (xi) an anti-CD34 antibody, (xii) an anti-CD45RA antibody, (xiii) an anti-CD7 antibody, (xiv) an anti-CD71 antibody, (xv) an anti-CD41/CD61 complex antibody or an anti- CD41 antibody and/or an anti-CD61 antibody (xvi) an anti-CD33 antibody and/or an anti- CD66b antibody, for identifying hematopoietic cell subtypes in an isolated sample, determining the relative frequency of hematopoietic cell subtypes in an isolated sample and/or quantifying the number of cells within hematopoietic cell subtypes in an isolated sample, wherein each of (i) to (xvi) is labelled with a different fluorochrome, wherein when (xvi) is an anti-CD33 antibody and an anti-CD66b antibody, the anti-CD33 antibody and anti-CD66b are labelled with the same fluorochrome, and wherein when (xv) is an anti-CD41 antibody and an anti-CD61 antibody, the anti-CD4 antibody and the anti-CD61 antibody are labelled with the same fluorochrome.
    • (i)抗CD3抗体,(ii)抗CD56抗体,(iii)抗CD14抗体,(iv)抗CD38抗体,(v) (vi)抗CD90抗体,(vii)抗CD135抗体,(viii)抗CD10抗体,(ix)抗CD11c抗体,(x)抗CD19抗体, (xi)抗CD34抗体,(xii)抗CD45RA抗体,(xiii)抗CD7抗体,(xiv)抗CD71抗体,(xv)抗CD41 / CD61复合体抗体或抗CD41抗体 -CD41抗体和/或抗CD61抗体(xvi)抗CD33抗体和/或抗CD66b抗体,用于鉴定分离的样品中的造血细胞亚型,确定分离的样品中造血细胞亚型的相对频率 和/或量化分离的样品中造血细胞亚型内细胞的数量,其中(i)至(xvi)中的每一个用不同的荧光染料标记,其中当(xvi)是抗CD33抗体和抗CD66b 抗体,抗CD33抗体和a nti-CD66b用相同的荧光染料标记,并且其中当(xv)是抗CD41抗体和抗CD61抗体时,用相同的荧光染料标记抗CD4抗体和抗CD61抗体。